Search results

Evidence-based recommendations on ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (MS) in adults

Type

Technology appraisal guidance

Published

12 June 2019

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin), carboplatin and paclitaxel for metastatic non-squamous non-small-cell

Type

Technology appraisal guidance

Published

05 June 2019

Evidence-based recommendations on ertugliflozin (Steglatro) with metformin and a dipeptidyl peptidase-4 inhibitor for type 2 diabetes in adults

Type

Technology appraisal guidance

Published

05 June 2019

Evidence-based recommendations on therapeutic hypothermia for acute ischaemic stroke in adults. This involves using a cooling device to reduce the body’s

Type

Interventional procedures guidance

Published

29 May 2019

Evidence-based recommendations on collagen paste for closing an anal fistula in adults

Type

Interventional procedures guidance

Published

29 May 2019

Evidence-based recommendations on percutaneous mitral valve leaflet repair for mitral regurgitation in adults

Type

Interventional procedures guidance

Published

29 May 2019

NICE is unable to make a recommendation about the use in the NHS of cabozantinib (Cometriq) for previously treated advanced hepatocellular carcinoma in adults

Type

Technology appraisal guidance

Published

24 May 2019

Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

Type

Highly specialised technologies guidance

Published

22 May 2019

Evidence-based recommendations on enzalutamide (Xtandi) for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults

Type

Technology appraisal guidance

Published

15 May 2019

Evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) for untreated advanced renal cell carcinoma that is intermediate- or poor-risk in

Type

Technology appraisal guidance

Published

15 May 2019

Evidence-based recommendations on abemaciclib (Verzenios) for treating hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer

Type

Technology appraisal guidance

Published

08 May 2019

Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic

Type

Diagnostics guidance

Published

08 May 2019

Evidence-based recommendations on durvalumab (Imfinzi) for treating locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation

Type

Technology appraisal guidance

Published

01 May 2019

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive cutaneous T-cell lymphoma in adults

Type

Technology appraisal guidance

Published

24 April 2019

Evidence-based recommendations on endoscopic ablation for a pilonidal sinus in adults

Type

Interventional procedures guidance

Published

17 April 2019

Evidence-based recommendations on tildrakizumab (Ilumetri) for treating moderate to severe plaque psoriasis in adults

Type

Technology appraisal guidance

Published

17 April 2019

NICE is unable to make a recommendation about the use in the NHS of bosutinib for untreated chronic myeloid leukaemia because no evidence submission was

Type

Technology appraisal guidance

Published

17 April 2019

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating moderate to severe plaque psoriasis in adults

Type

Technology appraisal guidance

Published

17 April 2019

Evidence-based recommendations on endoscopic ablation for an anal fistula in adults

Type

Interventional procedures guidance

Published

17 April 2019

Evidence-based recommendations on daratumumab (Darzalex) with bortezomib and dexamethasone for previously treated multiple myeloma in adults

Type

Technology appraisal guidance

Published

10 April 2019

Evidence-based recommendations on ertugliflozin (Steglatro) as monotherapy or with metformin for treating type 2 diabetes in adults

Type

Technology appraisal guidance

Published

27 March 2019

NICE is unable to make a recommendation about the use in the NHS of pembrolizumab (Keytruda) for treating recurrent or metastatic squamous cell carcinoma of the

Type

Technology appraisal guidance

Published

20 March 2019

Evidence-based recommendations on brigatinib (Alunbrig) for treating anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults who

Type

Technology appraisal guidance

Published

20 March 2019

Evidence-based recommendations on pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer in adults

Type

Technology appraisal guidance

Published

20 March 2019

Evidence-based recommendations on tisagenlecleucel therapy (Kymriah) for treating relapsed or refractory diffuse large B-cell lymphoma in adults after 2 or more

Type

Technology appraisal guidance

Published

13 March 2019

NICE is unable to make a recommendation on abatacept (Orencia) for treating psoriatic arthritis after DMARDs in adults because of no evidence submission from

Type

Technology appraisal guidance

Published

13 March 2019

Evidence-based recommendations on radially emitting laser fibre treatment of an anal fistula in adults

Type

Interventional procedures guidance

Published

13 March 2019

Evidence-based recommendations on cochlear implants for children and adults with severe to profound deafness

Type

Technology appraisal guidance

Published

07 March 2019

Evidence-based recommendations on venetoclax (Venclyxto) with rituximab for previously treated chronic lymphocytic leukaemia in adults

Type

Technology appraisal guidance

Published

27 February 2019

Evidence-based recommendations on encorafenib (Braftovi) with binimetinib (Mektovi) for treating unresectable or metastatic BRAF V600 mutation-positive melanoma

Type

Technology appraisal guidance

Published

27 February 2019

Evidence-based recommendations on abemaciclib (Verzenios) for treating locally advanced or metastatic, hormone receptor-positive, human epidermal growth factor

Type

Technology appraisal guidance

Published

27 February 2019

NICE is unable to make a recommendation about the use in the NHS of dabrafenib with trametinib for treating advanced metastatic BRAF V600E mutation-positive

Type

Technology appraisal guidance

Published

27 February 2019

Evidence-based recommendations on high-intensity focused ultrasound for symptomatic benign thyroid nodules in adults

Type

Interventional procedures guidance

Published

27 February 2019

Evidence-based recommendations on Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal

Type

Interventional procedures guidance

Published

20 February 2019

NICE is unable to make a recommendation about the use in the NHS of bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence

Type

Technology appraisal guidance

Published

20 February 2019

This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.

Type

Antimicrobial prescribing guideline

Published

07 February 2019

Evidence-based recommendations on percutaneous venoplasty for chronic cerebrospinal venous insufficiency in people with multiple sclerosis. This involves

Type

Interventional procedures guidance

Published

30 January 2019

Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia

Type

Interventional procedures guidance

Published

30 January 2019

Evidence-based recommendations on electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer in adults

Type

Interventional procedures guidance

Published

30 January 2019

Evidence-based recommendations on laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth

Type

Interventional procedures guidance

Published

30 January 2019

Evidence-based recommendations on platelet-rich plasma injections for knee osteoarthritis in adults. This involves taking plasma from a small amount of the

Type

Interventional procedures guidance

Published

23 January 2019

Evidence-based recommendations on nivolumab (Opdivo) for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease

Type

Technology appraisal guidance

Published

23 January 2019

Evidence-based recommendations on axicabtagene ciloleucel therapy (Yescarta) for treating diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma

Type

Technology appraisal guidance

Published

23 January 2019

Evidence-based recommendations on ex-situ machine perfusion for extracorporeal preservation of livers for transplantation in people of all ages

Type

Interventional procedures guidance

Published

16 January 2019

This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.

Type

NICE guideline

Published

15 January 2019

Evidence-based recommendations on pembrolizumab (Keytruda) with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung

Type

Technology appraisal guidance

Published

10 January 2019

Evidence-based recommendations on darvadstrocel (Alofisel; stem-cell treatment) for complex perianal fistulas with mildly or non-active luminal Crohn’s disease

Type

Technology appraisal guidance

Published

09 January 2019

Evidence-based recommendations on regorafenib (Stivarga) for treating advanced hepatocellular carcinoma (liver cancer) in adults who have had sorafenib

Type

Technology appraisal guidance

Published

09 January 2019

Evidence-based recommendations on tisagenlecleucel therapy (Kymriah) for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up

Type

Technology appraisal guidance

Published

21 December 2018

Evidence-based recommendations on lenvatinib (Lenvima) for untreated advanced hepatocellular carcinoma (HCC) in adults

Type

Technology appraisal guidance

Published

19 December 2018